Search For "pharma"
Elion Technologies: 15 Years of Fire-Free Facilities Through Proactive Saf
Updated : 10 months ago IST
New Delhi [India], May 20: With fire incidents making headlines across India in recent months--impacting hospitals, warehouses, offices, and even schools--the need for structured and regular fire safety audits has become more urgent than ever. Elion Technologies and Consulting Pvt Ltd, a lea
Read More
MediThinQ Enters China Through Strategic Partnership with Sinopharm, Makin
Updated : 10 months ago IST
Singapore, May 20: MediThinQ, the South Korean company specialising in wearable extended reality (XR) surgical displays, announced a strategic partnership with Sinopharm, a state-owned Chinese healthcare giant and the largest pharmaceutical and medical distribution company in China. This par
Read More
Julphar plans to invest AED 300 million over next five years: CEO
Updated : 10 months ago IST
Gulf Pharmaceutical Industries (Julphar) plans to invest AED 300 million over the next five years to expand its manufacturing capabilities and localise advanced technologies. CEO Basel Ziyadeh announced the move during the "Make it in the Emirates 2025" event, reinforcing Julphar's role in b
Read More
HVAX Technologies Achieves Robust Net Profit Growth of 30% in FY25
Updated : 10 months ago IST
Mumbai (Maharashtra) [India], May 19: HVAX Technologies Limited (NSE -HVAX), a turnkey pharmaceutical project integrator specializing in cleanroom infrastructure, HVAC systems, and engineering consultancy, has announced its Audited Financial Results for H2 and FY25.
Read More
From generic drugs to vaccines, Indian pharma industry is transforming liv
Updated : 10 months ago IST
India is the largest supplier of generic medicines providing 20 per cent of the world's supply and a key player in affordable vaccines.
Read More
Government Push for Generic Drugs Finds Digital Ally in New Healthcare Por
Updated : 10 months ago IST
Ahmedabad (Gujarat) [India], May 16: India's healthcare landscape is undergoing a significant transformation, led by national initiatives like Ayushman Bharat and the Jan Aushadhi Yojana. According to Ayushman Bharat Health Account, over 77 crore health cards have been issued under the schem
Read More
Generic pharma companies unlikely to be impacted by Trump's order to cut R
Updated : 10 months ago IST
Generic drug companies in India are not expected to be affected by US President Donald Trump's new order to bring the prices for prescription (Rx) drugs in line with other developed nations, says a report by HDFC Securities.
Read More
STEERLife Redefines Potent Drug Development with Clean, Green, Continuous
Updated : 10 months ago IST
Bengaluru (Karnataka) [India], May 15: STEERLife, the life sciences division of STEER World, is advancing the development and manufacturing of potent and complex drug products. This initiative marks a significant advancement in a field that has long been considered one of the most challengin
Read More
MoS Margherita oversees signing of MoU on Recognition of the Indian Pharma
Updated : 10 months ago IST
Margherita said it would help advance the cooperation between both the countries in the gamut of healthcare.
Read More
NMIMS Hosts Grand 22nd Convocation Ceremony for MBA HR, MBA Pharmaceutical
Updated : 10 months ago IST
New Delhi [India], May 13: SVKM's NMIMS, one of India's leading academic institutions, successfully hosted its 22nd Convocation Ceremony, celebrating the academic achievements of students from its MBA, MBA (Human Resources), MBA (Pharmaceutical Management) programs
Read More
India Solidifies Position as Most Attractive Global CDMO Destination: LoEs
Updated : 10 months ago IST
New Delhi [India], May 13: India is poised to lead the global biopharma outsourcing landscape, leveraging recent regulatory shifts to cement its status as the most attractive destination for CDMO services. According to a new report by LoEstro Advisors, the country's Contract Development and
Read More
Generics medicine industry unlikely to be impacted by Trump order: Indian
Updated : 10 months, 1 week ago IST
India's generics medicine industry is unlikely to be impacted by President Donald Trump's move to slash drug prices in the US drastically, said Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance (IPA).
Read More